Comprehensive Inhibition of Breast Cancer Progression Through CD39 Targeting and Paclitaxel: Modulating Cell Proliferation, Apoptosis, and Migration
Current Genetic Medicine Reports · 14.03.2026 · 14 (1)
DOI: 10.1007/s40142-026-00243-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Genetic Medicine Reports, online erschienen am 14.03.2026. Verfasst von Sahand Eslami und 4 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Eslami, S., Youshanlui, M. A., Baghbanzadeh, A., Jamali, F., & Baradaran, B. (2026). Comprehensive Inhibition of Breast Cancer Progression Through CD39 Targeting and Paclitaxel: Modulating Cell Proliferation, Apoptosis, and Migration. Current Genetic Medicine Reports, 14(1). https://doi.org/10.1007/s40142-026-00243-8
Vancouver
Eslami S, Youshanlui MA, Baghbanzadeh A, Jamali F, Baradaran B. Comprehensive Inhibition of Breast Cancer Progression Through CD39 Targeting and Paclitaxel: Modulating Cell Proliferation, Apoptosis, and Migration. Current Genetic Medicine Reports. 2026;14(1). doi:10.1007/s40142-026-00243-8
BibTeX
@article{Eslami2026,
author = {Eslami, Sahand and Youshanlui, Mahya Ahmadpour and Baghbanzadeh, Amir and Jamali, Fereshteh and Baradaran, Behzad},
title = {Comprehensive Inhibition of Breast Cancer Progression Through CD39 Targeting and Paclitaxel: Modulating Cell Proliferation, Apoptosis, and Migration},
journal = {Current Genetic Medicine Reports},
year = {2026},
volume = {14},
number = {1},
doi = {10.1007/s40142-026-00243-8}
}
EUVIMED